Tilray Brands (TLRY) Minority Interest (2020 - 2026)
Tilray Brands' (TLRY) quarterly Minority Interest came in at -$19.5 million in Q2 2026, up 11.11% YoY from -$17.5 million in Q2 2025, and up 38.71% on a QoQ basis from -$31.8 million in Q1 2026.
Tilray Brands (TLRY) Minority Interest (2020 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 7 years of Minority Interest data on file, last reported at -$19.5 million in Q2 2026.
- Quarterly Minority Interest rose 11.11% year-over-year to -$19.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$19.5 million (up 11.11% YoY) and the FY2026 annual result came in at -$19.5 million, up 11.11% from the prior year.
- Minority Interest advanced to -$19.5 million in Q2 2026, from -$31.8 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $42.6 million in Q2 2022 to a low of -$33.3 million in Q4 2025.
- A 5-year average of $2.1 million and a median of $3.1 million in 2023 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2022 — Minority Interest jumped 581.74% — and 2025, when it sank 8151.1%.
- Tracing TLRY's Minority Interest over 5 years: stood at $12.9 million in 2022, then jumped by 94.37% to $25.0 million in 2023, then sank by 177.23% to -$19.3 million in 2024, then slumped by 72.45% to -$33.3 million in 2025, then jumped by 41.58% to -$19.5 million in 2026.
- The last three Minority Interest figures came in at -$19.5 million (Q2 2026), -$31.8 million (Q1 2026), and -$33.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -19.47 Mn |
| Feb 28, 2026 | -31.76 Mn |
| Nov 30, 2025 | -33.32 Mn |
| Aug 31, 2025 | -20.09 Mn |
| May 31, 2025 | -21.90 Mn |
| Nov 30, 2024 | -19.32 Mn |
| Aug 31, 2024 | 5.32 Mn |
| May 31, 2024 | 272,000.00 |
| Feb 29, 2024 | -15.82 Mn |
| Nov 30, 2023 | 25.02 Mn |
| Aug 31, 2023 | 22.18 Mn |
| May 31, 2023 | 14.25 Mn |
| Feb 28, 2023 | 3.11 Mn |
| Nov 30, 2022 | 12.87 Mn |
| Aug 31, 2022 | 37.84 Mn |
| May 31, 2022 | 42.56 Mn |
| Feb 28, 2022 | 33.77 Mn |
| Nov 30, 2021 | 36.70 Mn |
| Aug 31, 2021 | 66.28 Mn |
| May 31, 2021 | 6.24 Mn |